Survival and safety of treatment with infliximab in the elderly population

被引：36

作者：

Chevillotte-Maillard, H

Ornetti, P

Mistrih, R

Sidot, C

Dupuis, J

Dellas, JA

Tavernier, C

Maillefert, JF

机构：

[1] Dijon Univ Hosp, Dept Rheumatol, Dijon, France

[2] J Bouveri Hosp, Dept Med & Rheumatol, Montceau Les Mines, France

[3] Hop Hotel Dieu, Dept Rheumatol, Le Creusot, France

[4] G Ramon Hosp, Dept Rheumatol, Sens, France

[5] Univ Burgundy, INSERM, ERIT M 0207, Dijon, France

来源：

RHEUMATOLOGY | 2005年 / 44卷 / 05期

关键词：

D O I：

10.1093/rheumatology/keh562

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：695 / 696

页数：3

共 10 条

[1]

Cairns AP, 2002, ULSTER MED J, V71, P101

[2] Adverse reactions to TNF-α inhibitors in rheumatoid arthritis [J].

Day, R .

LANCET, 2002, 359 (9306) :540-541

[3]

Furst DE, 2004, J RHEUMATOL, V31, P1476

[4] Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk -: A multicenter active-surveillance report [J].

Gómez-Reino, JJ ;

Carmona, L ;

Valverde, VR ;

Mola, EM ;

Montero, MD .

ARTHRITIS AND RHEUMATISM, 2003, 48 (08) :2122-2127

[5] Anti-tumour necrosis factor a therapy in rheumatoid arthritis: an update on safety [J].

Hyrich, KL ;

Silman, AJ ;

Watson, KD ;

Symmons, DPM .

ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 (12) :1538-1543

[6] Serious bacterial infections in patients with rheumatoid arthritis under anti-TNF-α therapy [J].

Kroesen, S ;

Widmer, AF ;

Tyndall, A ;

Hasler, P .

RHEUMATOLOGY, 2003, 42 (05) :617-621

[7]

Kwoh CK, 2002, ARTHRITIS RHEUM-US, V46, P328

[8]

LEDINGHAM J, UPDATE BSR GUIDELINE

[9]

MAILLARD H, IN PRESS JOINT BONE

[10]

Weisman MH, 2002, J RHEUMATOL, V29, P33

← 1 →